Gene variants associated with age at menopause are also associated with polycystic ovary syndrome, gonadotrophins and ovarian volume

Human Reproduction

Volumn 30, Issue 7, 2015, Pages 1697-1703

  Saxena, R ^a   Bjonnes, A C ^a   Georgopoulos, N A ^b   Koika, V ^b   Panidis, D ^b,c   Welt, C K ^d  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b UNIVERSITY OF PATRAS   (Greece)

^c ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^d UNIVERSITY OF UTAH   (United States)

Author keywords

genetic variant; LH; ovarian volume; ultrasound

Indexed keywords

FOLLITROPIN; GONADOTROPIN; LUTEINIZING HORMONE; PROGESTERONE;

ADULT; AGE; ARTICLE; CASE CONTROL STUDY; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENE LOCUS; GENETIC ASSOCIATION; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE; GREECE; HUMAN; HYPERANDROGENISM; MAJOR CLINICAL STUDY; MENOPAUSE; MENSTRUAL CYCLE; NATIONAL HEALTH ORGANIZATION; ORGAN SIZE; OVARY; OVARY POLYCYSTIC DISEASE; QUANTITATIVE TRAIT; UNITED STATES; BLOOD; CLINICAL TRIAL; COHORT ANALYSIS; DIAGNOSTIC IMAGING; ECHOGRAPHY; GENETIC PREDISPOSITION; GENETIC VARIATION; GENETICS; MASSACHUSETTS; MIDDLE AGED; MULTICENTER STUDY;

EUNICE;

AGE FACTORS; BOSTON; CASE-CONTROL STUDIES; COHORT STUDIES; FEMALE; FOLLICLE STIMULATING HORMONE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENETIC VARIATION; GREECE; HUMANS; HYPERANDROGENISM; LUTEINIZING HORMONE; MENOPAUSE; MIDDLE AGED; OVARY; POLYCYSTIC OVARY SYNDROME; ULTRASONOGRAPHY;

EID: 84936791975     PISSN: 02681161     EISSN: 14602350     Source Type: Journal    
DOI: 10.1093/humrep/dev110     Document Type: Article

References (34)

1. Abel MH, Widen A, Wang X, Huhtaniemi I, Pakarinen P, Kumar TR, Christian HC. Pituitary gonadotrophic hormone synthesis, secretion, subunit gene expression and cell structure in normal and follicle-stimulating hormone beta knockout, follicle-stimulating hormone receptor knockout, luteinising hormone receptor knockout, hypogonadal and ovariectomised female mice. J Neuroendocrinol 2014;26:785-795.
2. Alsamarai S, Adams JM, Murphy MK, Post MD, Hayden DL, Hall JE, Welt CK. Criteria for polycystic ovarian morphology in polycystic ovary syndrome as a function of age. J Clin Endocrinol Metab 2009;94:4961-4970.
3. Angulo L, Perreau C, Lakhdari N, Uzbekov R, Papillier P, Freret S, Cadoret V, Guyader-Joly C, Royere D, Ponsart C et al. Breast-cancer anti-estrogen resistance 4 (BCAR4) encodes a novel maternal-effect protein in bovine and is expressed in the oocyte of humans and other non-rodent mammals. Hum Reprod 2013;28:430-441.
4. Consortium GT. The genotype-tissue expression (GTEx) project. Nat Genet 2013;45:580-585.
5. Coquery CM, Erickson LD. Regulatory roles of the tumor necrosis factor receptor BCMA. Crit Rev Immunol 2012;32:287-305.
6. Cornelis MC, Qi L, Zhang C, Kraft P, Manson J, Cai T, Hunter DJ, Hu FB. Joint effects of common genetic variants on the risk for type 2 diabetes in U. S. men and women of European ancestry. Ann Intern Med 2009; 150:541-550.
7. Delage MM, Dutertre S, Le Guevel R, Frolova L, Berkova N. Monoclonal antibodies against human translation termination factor eRF3 and their utilization for sub-cellular localization of eRF3. J Biochem 2011;150:49-59.
8. de Vet A, Laven JS, de Jong FH, Themmen AP, Fauser BC. Anti-Mullerian hormone serum levels: a putative marker for ovarian aging. Fertil Steril 2002;77:357-362.
9. Fortin J, Boehm U, Deng CX, Treier M, Bernard DJ. Follicle-stimulating hormone synthesis and fertility depend on SMAD4 and FOXL2. FASEB J 2014;28:3396-3410.
10. Georgopoulos NA, Karagiannidou E, Koika V, Roupas ND, Armeni A, Marioli D, Papadakis E, Welt CK, Panidis D. Increased frequency of the anti-Mullerian-inhibiting hormone receptor 2 (AMHR2) 482 A. G polymorphism in women with polycystic ovary syndrome: relationship to luteinizing hormone levels. J Clin Endocrinol Metab 2013; 98:E1866-E1870.
11. Gougeon A. Human ovarian follicular development: from activation of resting follicles to preovulatory maturation. Ann Endocrinol (Paris) 2010; 71:132-143.
12. He C, Kraft P, Chen C, Buring JE, Pare G, Hankinson SE, Chanock SJ, Ridker PM, Hunter DJ, Chasman DI. Genome-wide association studies identify loci associated with age at menarche and age at natural menopause. Nat Genet 2009;41:724-728.
13. Kottler ML, Chou YY, Chabre O, Richard N, Polge C, Brailly-Tabard S, Chanson P, Guiochon-Mantel A, Huhtaniemi I, Young J. A new FSHbeta mutation in a 29-year-old woman with primary amenorrhea and isolated FSH deficiency: functional characterization and ovarian response to human recombinant FSH. Eur J Endocrinol 2010;162:633-641.
14. Maciel GA, Baracat EC, Benda JA, Markham SM, Hensinger K, Chang RJ, Erickson GF. Stockpiling of transitional and classic primary follicles in ovaries of women with polycystic ovary syndrome. J Clin Endocrinol Metab 2004;89:5321-5327.
15. Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 1959;22:719-748.
16. Marchini J, Howie B, Myers S, McVean G, Donnelly P. A new multipoint method for genome-wide association studies by imputation of genotypes. Nat Genet 2007;39:906-913.
17. McCarroll SA, Huett A, Kuballa P, Chilewski SD, Landry A, Goyette P, Zody MC, Hall JL, Brant SR, Cho JH et al. Deletion polymorphismupstream of IRGM associated with altered IRGM expression and Crohn's disease. Nat Genet 2008;40:1107-1112.
18. McCarthy MI, Hirschhorn JN. Genome-wide association studies: potential next steps on a genetic journey. Hum Mol Genet 2008;17:R156-R165.
19. Mulders AG, Laven JS, Eijkemans MJ, de Jong FH, Themmen AP, Fauser BC. Changes in anti-Mullerian hormone serum concentrations over time suggest delayed ovarian ageing in normogonadotrophic anovulatory infertility. Hum Reprod 2004;19:2036-2042.
20. MurrayA, Bennett CE, Perry JR, WeedonMN, Jacobs PA, MorrisDH, Orr N, Schoemaker MJ, Jones M, Ashworth A et al. Common genetic variants are significant risk factors for early menopause: results from the Breakthrough Generations Study. Hum Mol Genet 2011;20:186-192.
21. Nelson VL, Legro RS, Strauss JF III, McAllister JM. Augmented androgen production is a stable steroidogenic phenotype of propagated theca cells from polycystic ovaries. Mol Endocrinol 1999;13:946-957.
22. Patterson N, Price AL, ReichD. Population structure and eigenanalysis. PLoS Genet 2006;2:e190.
23. Pigny P, Merlen E, Robert Y, Cortet-Rudelli C, Decanter C, Jonard S, Dewailly D. Elevated serum level of anti-Mullerian hormone in patients with polycystic ovary syndrome: relationship to the ovarian follicle excess and to the follicular arrest. J Clin Endocrinol Metab 2003;88:5957-5962.
24. Price AL, Patterson NJ, Plenge RM, Weinblatt ME, Shadick NA, Reich D. Principal components analysis corrects for stratification in genome-wide association studies. Nat Genet 2006;38:904-909.
25. Rebar R, Judd HL, Yen SS, Rakoff J, Vandenberg G, Naftolin F. Characterization of the inappropriate gonadotropin secretion in polycystic ovary syndrome. J Clin Invest 1976;57:1320-1329.
26. Rotterdam EA-SPcwg. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod 2004;19:41-47.
27. Schmidt J, Brannstrom M, Landin-Wilhelmsen K, Dahlgren E. Reproductive hormone levels and anthropometry in postmenopausal women with polycystic ovary syndrome (PCOS): a 21-year follow-up study of women diagnosed with PCOS around 50 years ago and their age-matched controls. J Clin Endocrinol Metab 2011;96:2178-2185.
28. Stolk L, Zhai G, van Meurs JB, Verbiest MM, Visser JA, Estrada K, Rivadeneira F, Williams FM, Cherkas L, Deloukas P et al. Loci at chromosomes 13, 19 and 20 influence age at natural menopause. Nat Genet 2009;41:645-647.
29. Stolk L, Perry JR, Chasman DI, He C, Mangino M, Sulem P, Barbalic M, Broer L, Byrne EM, Ernst F et al. Meta-analyses identify 13 loci associated with age at menopause and highlight DNA repair and immune pathways. Nat Genet 2012;44:260-268.
30. Taylor AE, McCourt B, Martin KA, Anderson EJ, Adams JM, Schoenfeld D, Hall JE. Determinants of abnormal gonadotropin secretion in clinically defined women with polycystic ovary syndrome. J Clin Endocrinol Metab 1997;82:2248-2256.
31. van DorpW, van den Heuvel-EibrinkMM, Stolk L, Pieters R, Uitterlinden AG, Visser JA, Laven JS. Genetic variation may modify ovarian reserve in female childhood cancer survivors. Hum Reprod 2013;28:1069-1076.
32. Waldstreicher J, Santoro NF, Hall JE, Filicori M, Crowley WF Jr. Hyperfunction of the hypothalamic-pituitary axis in women with polycystic ovarian disease: indirect evidence for partial gonadotroph desensitization. J Clin Endocrinol Metab 1988;66:165-172.
33. Welt CK, Arason G, Gudmundsson JA, Adams J, Palsdottir H, Gudlaugsdottir G, Ingadottir G, Crowley WF. Defining constant versus variable phenotypic features of women with polycystic ovary syndrome using different ethnic groups and populations. J Clin Endocrinol Metab 2006;91:4361-4368.
34. Welt CK, Styrkarsdottir U, Ehrmann DA, Thorleifsson G, Arason G, Gudmundsson JA, Ober C, Rosenfield RL, Saxena R, Thorsteinsdottir U et al. Variants in DENND1A are associated with polycystic ovary syndrome in women of European ancestry. J Clin Endocrinol Metab 2012; 97:E1342-E1347.